News, stories & comment

Merck logo FDA approves JANUMET® XR (sitagliptin and metformin HCl extended-release) for type 2 diabetes

2 February 2012
JANUMET XR can help many patients reach blood sugar goals...

AstraZeneca AstraZeneca to cut a further 7,300 jobs

2 February 2012
AstraZeneca has announced new restructuring initiatives designed to improve productivity...

Novartis logo FDA approves Novartis drug Glivec® label

1 February 2012
The US Food and Drug Administration has approved an update to the Glivec® (imatinib)* label...

Pfizer logo Private and public partners unite to combat 10 neglected tropical diseases by 2020

30 January 2012
Partners pledge innovative, coordinated action aimed at new WHO goals...

Novartis logo Novartis extends commitment to help achieve final elimination of leprosy

30 January 2012
Novartis is a part of an international effort to eliminate or control 10 NTDs by the end of the decade...

Eli Lilly logo FDA approves Jentadueto™ (linagliptin/metformin hydrochloride) tablets for the treatment of adult patients with type 2 diabetes

30 January 2012
Jentadueto™ tablets approved...

Featured whitepaper

OGT logo

Whitepaper: Autoantibody biomarker panels for improved disease diagnosis

Source: Oxford Gene Technology
Download this free white paper for detailed insight into the advantages of autoantibodies as biomarkers, including a review of the current technology and best practices for identification of sensitive and specific autoantibody biomarkers.

Subscriptions & membership

Become a subscriber today for just £90 and receive:

  • the next six issues of European Pharmaceutical Review magazine,
  • online access to hundreds of articles from our back issue archive, and much more...

And if you subscribe for 2 years you'll save 25%!

Subscribe today >>

Request trial subscription >>

Articles by topic

Browse our magazine back issue archive by topic: